Preliminary list as of April 16

AbSano BV
A Human mAb Cocktail Combatting Most Common Variants of SARS-CoV-2

Ajinomoto Co., Inc.
Single-Chain Tandem Macrocyclic Peptides (STaMPs) as a Novel Multivalent Molecular Format

Ajinomoto Co., Inc.
Introduction of 2nd Generation AJICAP® Technology- Expansion of Chemical Site-Specific Conjugation Capabilities

HCP Profiler: Reproducible Host Cell Proteins Identification and Quantification to Compare Different Batches

Bruker Scientific LLC
Usage of 6 Infinity Stones to Make an SPR Instrument? The Pro Series Instruments

Cayman Chemical
Production and Characterization of N- and C-Terminal Selenocysteine Proteins

Charles River Laboratories
In Vitro Efficacy Studies to Support Engineered T Cell Therapies

Crescendo Biologics
Humabody* V[H]: A Versatile Platform for Generation of Novel Therapeutics

Cygnal Therapeutics
Delaying Tumor Growth Through Anti-Neuropilin-1 Antibodies Which Bind to Novel Epitopes

Duke University
Scalable Production of Griffithsin, a Broad-Spectrum Antiviral Protein and Anti-COVID-19 Candidate

Duke University
Two-Stage Dynamic Control Over Redox State Improves Cytosolic Expression of Disulfide Containing Proteins in E. coli

Dyadic International, Inc.
Making Healthcare Accessible and Affordable to Patients Globally Through the Adoption and Use of an Engineered Eukaryotic Filamentous Fungal Cell Line, C1, that Markedly Improves Protein Yields and Lowers the Cost of Manufacturing Biologic Vaccines and Dr

Eli Lilly and Company
Using Extrinsic Fluorescent Probe Bis-ANS to Measure Protein Surface Hydrophobicity

EpimAb Biotherapeutics
Fabs-in-Tandem Bispecific T-Cell Engager for Efficient Tumor Killing and Minimal Cytokine Release

Eurofins DiscoverX
Quantify Diverse Immune Cell-Mediated Killing Mechanisms: Applications of a Robust, Non-Radioactive KILR Cytotoxicity Platform

Eurofins DiscoverX
Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors

Fina Biosolutions LLC
Engineered E. coli with an Oxidative Cytoplasm and Efficient Cleavage of N-Terminal Methionine

Genentech, Inc.
Measurement of a Humanized Fab Molecule in Three Different Ocular Matrices Utilizing One Assay Method

Genentech, Inc.
Complementary Methods to Characterize and Quantitate Intact Stability of Novel Drug Modalities Using Capillary Electrophoresis Western Blot and Affinity Capture Coupled to LC-MS

Halo Labs
Protein or Not? Advanced Subvisible Particle Characterization with Fluorescent ID

Halo Labs
Introducing the Aura CL for Cell and Gene Therapy Aggregation, Particle Analysis and ID

Hospital for Sick Children Research Institute
Multivalency Transforms SARS-CoV-2 Antibodies into Ultrapotent Neutralizers

Immatics Biotechnologies GmbH
Targeting of Tumor-Specific Peptide Antigens with Bispecific T Cell-Engaging Receptor (TCER) Molecules

Integrated Micro-Chromatography Systems, Inc. (IMCS)
Evaluation of LigaTrap™ Resins in IMCStips® for the High-Throughput Purification of Immunoglobulins

Integrated Micro-Chromatography Systems, Inc. (IMCS)
Automated High Throughput Protein Purification > 5 mL Samples Using Affinity IMCStips®

Ixaka France
Development of In Vivo Anti-CD19 CAR T-Cell Therapy Based on Hybrid Nanoparticles

JASCO Corporation
A Novel Method of High-Sensitive HOS Assessment and Thermal Stability Evaluation of Anti-SARS-CoV-2 Antibody Using Circular Dichroism Spectrometer

KBIO Osong Medical Innovation Foundation
BhTS (Barcoded HTS) Platform to Improve Productivity of Biopharmaceuticals using 1200 Human Secretory Signal Peptides

KBIO Osong Medical Innovation Foundation
Multi-Omics Analysis for Characterization of Extracellular Vesicle

Massachusetts Institute of Technology
Calculation of Therapeutic Antibody Viscosity with Coarse-Grained Models, Hydrodynamic Calculations and Machine Learning-Based Parameters

Merck & Co., Inc.
A Sequential Intact Mass - PRM Workflow to Characterize In Vivo Clipping of Novel Biologics by LC-MS: Cytokine-Fc Biotransformation Case Study

Merck & Co., Inc.
A Novel Approach for Identifying Acid Dissociation Conditions to Support Immunogenicity Assay Development

National Institute of Advanced Industrial Science and Technology (AIST)
Directed Evolution of Non-Immunoglobulin Scaffold Proteins Against a Cancer Marker

Pandion Therapeutics, Inc.
Engineering of Skin-Targeting Bispecific Antibodies that Drive Localized Immune Modulation in Autoimmune and Inflammatory Diseases

PhyNexus, now part of Biotage
Automated Plasmid Prep and Optimized Protein Separation Using PhyTip® Columns

Improving Transient CHO and HEK-293 Expression Systems with a Powerful Transfection Solution for High Protein Production Yields: FectoPRO®

Promega Corporation
Quantitative Cell-Based Reporter Gene Bioassays to Advance Individual or Combination Cancer Immunotherapy

Promega Corporation
A Homogenous PBMC ADCC Bioassay Enables Bridging Studies with ADCC Reporter Bioassays in Immunotherapy Monoclonal Antibody Development

Promega Corporation
Novel Bioluminescent Bioassays for the Discovery and Development of Molecular and Cellular T-Cell Redirecting Cancer Therapy

Proteros USA, Inc.
Protein Production, Biochemical and Biophysical Characterization as Well as X-Ray Crystallography and Cryo-EM for Biologicals During Early Drug Discovery

Repertoire Immune Medicines
Cell-Tethered IL-12 Improves Anti-Tumor Efficacy of Adoptive T Cell Therapy

Retrogenix Ltd.
Identifying Specific Cell Surface Heterodimer Receptors and Off-Targets: Integrin and CD3 Receptor Examples

Roche Diagnostics GmbH
From Sample to Report: Automating MS Analytics of Next-Generation Protein Therapeutics

Sandia National Laboratories
Development of Potent and Effective SARS-CoV-2 Nanobodies

Fine Tuning of the Temperature in Sodium Dodecyl Sulfate Capillary Gel Electrophoresis (CE-SDS) for Better Separation Resolution of New Biopharmaceutical Modalities

From Peptides to Intact Mass Analysis: A Flexible Solution for Monitoring Multiple Attributes

Sino Biological US, Inc.
Generation of Functional Monoclonal Antibodies by Single B Cell Cloning

Svar Life Science AB
Characterization of a Reporter Gene Cell Line for the Easy Assessment of Therapeutic AAV Vectors – A Case Study

UniTargetingResearch AS
Selected Regulatory Elements to Enhance the Efficacy of mRNA Vaccines

University of California, Santa Cruz
A Simplified Workflow for Monoclonal Antibody Sequencing

University of Liege
Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC in the Multiple Myeloma Context

University of Macau
B7-H3/CD16 Bispecific Killer Cell Engagers for Therapy of Non-Small Lung Cell Cancer

University of Minnesota - Twin Cities
Engineering Cell-Based Selections for Translatable Ligand Discovery

University of the Basque Country
Potency Enhancement of HIV-1 Neutralizing Antibodies by Site-Specific Chemical Modification

University of the Basque Country
Focal Accumulation of Aromaticity at the CDRH3 Loop Mitigates 4E10 Polyreactivity Without Altering Its HIV Neutralization Profile

University of Turku
Nanomolar Protein-Probe Antibody Aggregation Assay

Walter and Eliza Hall Institute of Medical Research
Engineering Antibodies to Trigger BAK-Mediated Apoptosis in Cancer